Diarylazoles with promising anti-oomycete and antifungal properties

Overview

This solution centers on a class of diarylazole compounds developed to combat oomycete and fungal pathogens. The compounds were designed, synthesized, and iteratively refined based on data gathered from multiple rounds of phenotypic screenings, a discovery approach that evaluates biological activity at the whole-organism level rather than against isolated molecular targets. The result is a promising chemical scaffold with demonstrated anti-oomycete and antifungal properties, suitable for further development in crop protection, agricultural disease management, and potentially pharmaceutical antifungal applications.

Technical specifications

• Compound class: Diarylazoles — small molecules featuring two aryl groups attached to an azole core
• Discovery approach: Phenotypic screening, which tests compounds directly against living pathogens to capture activity, potency, and cellular permeability in a single assay
• Optimization process: Multiple iterative rounds of design, synthesis, and biological evaluation to refine activity and selectivity
• Biological activity: Demonstrated efficacy against both oomycetes (water molds such as Phytophthora and Pythium species) and fungi
• Potential applications: Agricultural fungicides, seed treatments, and antifungal agents for crop or non-crop use

Technology readiness level

The compounds have progressed through several rounds of phenotypic screening-based optimization, indicating an early-to-mid stage of preclinical development. Further validation work, including broader spectrum-of-activity testing, formulation development, and field or in vivo efficacy studies, would be required to advance toward commercial readiness.